Cardiac Elastography Measurement : an Intraoperative Cardiac Surgery Study (REA-FO)

January 9, 2015 updated by: University Hospital, Caen

Measurement of Cardiac Elastography: an Intraoperative Cardiac Surgery Study. Cardiac Elastography in Vivo

Since 20 years, the techniques of direct measurement of cardiac stiffness in the diagnosis of myocardial diseases do not exist.

We propose a human study evaluating the direct measurement of cardiac ultrasound stiffness by elastography.

This study will include 30 patients with cardiac disease whose rigidity varies with underlying disease.

The purpose of this study is to evaluate the stiffness during open heart surgery.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Basse Normandie
      • Caen, Basse Normandie, France, 14033
        • Recruiting
        • CAEN University Hospital
        • Principal Investigator:
          • Eric saloux, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Consecutive patients undergoing cardiac surgery

Description

Inclusion Criteria:

  • Written consent
  • Patients older than 18 years
  • Every patient scheduled for cardiac surgery
  • Cardiac catheterization within 6 months before surgery,
  • Women of childbearing age in effective contraception (a urine pregnancy test will be performed)
  • Patient affiliated or covered by a plan of health insurance.
  • Francophone

Exclusion Criteria:

  • Pregnant or lactating woman,
  • Functional walking disability,
  • Patient placed under judicial protection: guardianship,
  • Patient participating in another trial and / or participated in another trial within two months,
  • Patient under guardianship or trusteeship,
  • Women who are not effective contraception,
  • Patient with no liberty by administrative or judicial decision

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Young's Modulus measurement according to the equation E = Young 3ρCs ²
Time Frame: During herat surgery (Day 0)

Ultrasound acquisition will be completed in epicardial vue using a linear probe SuperLinear 15-4 ™ connected to an ultrasound (AixplorerTM ® from Supersonic Imagine). The acquisitions will be completed in mode B + Elastrography Shear Wave ™ (SWE). A sterile gel is deposited in the bottom of the pouch of sterile protection of the probe. Many measurements will be done on accessible left and right ventricle areas.

Measurement of Young's modulus: automated by the onboard model according to the equation E = Young 3ρCs ², where E is the Young's elastic modulus software, ρ is the tissue density and Cs the velocity of shear wave

During herat surgery (Day 0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diastolic function parameters
Time Frame: Day 0
Correlation between young's modulus and diastolic function parameters is assess after surgery by post processing
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Fabrice Bauer, MD,PhD, ROUEN university hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

October 25, 2013

First Submitted That Met QC Criteria

January 29, 2014

First Posted (Estimate)

January 31, 2014

Study Record Updates

Last Update Posted (Estimate)

January 12, 2015

Last Update Submitted That Met QC Criteria

January 9, 2015

Last Verified

January 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • REA-FO-2013-A00593-42

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diastolic Dysfunction and Cardiac Stiffness

3
Subscribe